Detalles de la búsqueda
1.
TransCatheter aortic valve implantation and fractional flow reserve-guided percutaneous coronary intervention versus conventional surgical aortic valve replacement and coronary bypass grafting for treatment of patients with aortic valve stenosis and multivessel or advanced coronary disease: The transcatheter valve and vessels trial (TCW trial): Design and rationale.
Am Heart J
; 270: 86-94, 2024 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-38309610
2.
Bifurcation PCI with a hybrid strategy with drug- eluting balloons versus a stepwise provisional two- stent strategy: Rationale and design of the hybrid DEB study.
Am Heart J
; 266: 168-175, 2023 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-37806333
3.
Angiography-derived physiology guidance vs usual care in an All-comers PCI population treated with the healing-targeted supreme stent and Ticagrelor monotherapy: PIONEER IV trial design.
Am Heart J
; 246: 32-43, 2022 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-34990582
4.
Acute myocardial infarction treated with novel Resolute Onyx and Orsiro stents in the randomized BIONYX trial.
Catheter Cardiovasc Interv
; 98(2): E188-E196, 2021 08 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33694294
5.
A global registry of fractional flow reserve (FFR)-guided management during routine care: Study design, baseline characteristics and outcomes of invasive management.
Catheter Cardiovasc Interv
; 96(4): E423-E431, 2020 10 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-32170905
6.
Thin composite wire strut, durable polymer-coated (Resolute Onyx) versus ultrathin cobalt-chromium strut, bioresorbable polymer-coated (Orsiro) drug-eluting stents in allcomers with coronary artery disease (BIONYX): an international, single-blind, randomised non-inferiority trial.
Lancet
; 392(10154): 1235-1245, 2018 10 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-30253879
7.
Very thin strut biodegradable polymer everolimus-eluting and sirolimus-eluting stents versus durable polymer zotarolimus-eluting stents in allcomers with coronary artery disease (BIO-RESORT): a three-arm, randomised, non-inferiority trial.
Lancet
; 388(10060): 2607-2617, 2016 11 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-27806902
8.
Final 5-Year Report of the Randomized BIO-RESORT Trial Comparing 3 Contemporary Drug-Eluting Stents in All-Comers.
J Am Heart Assoc
; 11(22): e026041, 2022 11 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-36346050
9.
Thin Composite-Wire-Strut Zotarolimus-Eluting Stents Versus Ultrathin-Strut Sirolimus-Eluting Stents in BIONYX at 2 Years.
JACC Cardiovasc Interv
; 13(9): 1100-1109, 2020 05 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-32381186
10.
Thin, Very Thin, or Ultrathin Strut Biodegradable or Durable Polymer-Coated Drug-Eluting Stents: 3-Year Outcomes of BIO-RESORT.
JACC Cardiovasc Interv
; 12(17): 1650-1660, 2019 09 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-31422087
11.
Diagnostic Performance of In-Procedure Angiography-Derived Quantitative Flow Reserve Compared to Pressure-Derived Fractional Flow Reserve: The FAVOR II Europe-Japan Study.
J Am Heart Assoc
; 7(14)2018 07 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-29980523
12.
Direct drug-eluting stenting to reduce stent restenosis: a randomized comparison of direct stent implantation to conventional stenting with pre-dilation or provisional stenting in elective PCI patients.
JACC Cardiovasc Interv
; 7(7): 751-8, 2014 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-25060017
Resultados
1 -
12
de 12
1
Próxima >
>>